Neubourg macht nachhaltigen Schritt in die Zukunft

AVIAPharma joinsGreven’sfootcarespecialists

Greven in February2024. neubourgskincare-GmbHis nowpartof AVIAPharma. On February1, ownerandManagingDirectorDr. Thomas Neubourgsoldhissharesto theSwedishcompany. Theneubourggroupof companiesis thusenteringthefuturewitha strongpartner. Thecommongoalis to poolexpertiseandfurtherexpandtheportfolioin theskin, footandnailcaresector. Thetakeoverby Aviais also associatedwitha changein management. Stefan Lang is thenewManagingDirectorof neubourgskincareGmbH, whileThomas Neubourgwill remainwiththecompanyas a consultant.

TheGermancompanyneubourg, basedin Greven, hasbeena specialistin foam-basedmedicalskinandfootcareforover25 years. Today, neubourgskincareGmbH'sportfolioincludesthemarketleaderAllpresanas wellas otherproductlinessuch as Podoexpert, Onyfix, Fußpunkt, Sixtus andSkincare. Withannualsalesof around15 millioneurosandaround70 employees, neubourgcontributesto Avia'splan to acquireandfurtherdevelopstronglocalbrandsin Germany, Austria andSwitzerland. AviaPharma focuseson thekeyareasof dermatology, allergology, women'shealth andurologyandOTCbrandedproductssuch as Nix, Duroferon, AllergikaandnowAllpresan.

Bild von Thomas Neubourg, ehem. Inhaber und Geschäftsführer der neubourg group
Thomas Neubourg, ehem. Inhaber und Geschäftsführer der neubourg group

"I believe that Avia gives our company, our employees and, above all, our customers a strong and long-term perspective. Avia is in a position to further develop our brands and take the next steps," says Thomas Neubourg.

Neubourg sees the exchange with another German Avia subsidiary, the pharmaceutical company Allergika, in particular as an opportunity.

Jacob Calmvik, co-founder and CEO of Avia, also expressed his enthusiasm for the integration of the neubourg group and emphasized his company's focus on acquiring first-class local brands such as Allpresan.

Stefan Lang, CEO & Managing Director


Under the management of Avia, the company location in Greven will be retained. The customer care concept is to be further optimized in the future and take even greater account of the day-to-day practice of foot care and podiatry. In concrete terms, this means less field service on site and more events that are easier to plan and integrate into the practice processes.

Stefan Lang, new Managing Director of neubourg skin care GmbH: "As the new Managing Director of neubourg group, I want to successfully develop the long-standing business relationship. My team and I will do everything we can to ensure that our customers continue to feel well looked after by us." 


About neubourg: neubourg skin care GmbH, founded in 1998, is a medium-sized German medical skin and foot care company based in Greven. It specializes in skin, foot and nail care products, including the market leader in foam-based foot care Allpresan. Today, the medium-sized family business is widely known as the "foam cream specialist from the Münsterland region". Since 2018, neubourg skin care GmbH has proudly held the Top Innovator seal, making it one of the innovation leaders in Germany. Neubourg has 70 employees and generates an annual turnover of 15 million euros.

About Avia Pharma: Avia is a leading Swedish OTC/Rx distribution platform with a presence in Scandinavia and Germany. Its focus is on medically positioned products within dermatology, allergology, women's health, urology and OTC products with well-known brands such as Nix, Duroferon and Allergika. With the recent acquisition of the Allpresan brand and other Neubourg brands, Avia's annual sales exceed SEK 600 million (EUR 53 million).